Malaysia Airlines has deployed an AI agent called Mavis, built on Ada's agentic customer experience platform, to handle flight status checks, seat upgrades and check-ins around the clock in English and Malay.
Accor has launched its ALL Concierge AI chatbot across roughly 5,800 hotels worldwide after a pilot that logged more than one million guest conversations, the largest full-scale conversational AI rollout yet by a major hotel group.
White Rock Medical Center in Dallas went live on June 23, 2026 with PurpleAI's FDA-cleared intracranial hemorrhage triage AI, integrated into its existing PACS via Savelife.AI's ConnectAI module.
The FDA cleared version 1.2 of Lunit's INSIGHT DBT breast tomosynthesis AI on March 26, 2026, adding automatic current-prior comparison across up to two years of mammograms and configurable sensitivity thresholds.
Tempus AI's ECG-PH, its third FDA-cleared cardiovascular device, analyzes a standard 12-lead ECG to flag signs of pulmonary hypertension in symptomatic patients 40 and older.
Anumana's ECG-AI algorithm for cardiac amyloidosis, cleared by the FDA on April 8, 2026, detected the disease with 78.9% sensitivity and 91.2% specificity across a 25,525-patient, four-health-system study.
EchoNext, trained on 700,000 paired ECG-echocardiogram records at NewYork-Presbyterian and Columbia, won FDA clearance on June 22, 2026 to flag six forms of structural heart disease from a routine ECG alone.
CapsoVision's AI Highlights, cleared by the FDA on September 25, 2026, scans tens of thousands of capsule endoscopy frames to flag suspected small bowel bleeding lesions for physician review.
Mexico is piloting AI-assisted mammography reading tools in public clinics to cut the long wait between a screening mammogram and a diagnosis, Al Jazeera reported on October 3, 2026. The push comes as a shortage of radiologists and oncologists leaves many women, especially outside major cities, waiting weeks or months for results.
Bunkerhill Health has won FDA clearance for the first AI algorithm to detect and measure mitral annular calcification on routine chest CT scans ordered for unrelated reasons, such as lung cancer screening. The tool could turn millions of existing scans into opportunities to catch a heart condition linked to higher cardiovascular mortality, though cardiologists say the clinical response to a positive flag still needs to be defined.